KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Opko Health (OPK) Interest Expenses (2016 - 2025)

Historic Interest Expenses for Opko Health (OPK) over the last 15 years, with Q3 2025 value amounting to $11.4 million.

  • Opko Health's Interest Expenses fell 3457.0% to $11.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.4 million, marking a year-over-year increase of 20369.98%. This contributed to the annual value of $47.5 million for FY2024, which is 25143.64% up from last year.
  • As of Q3 2025, Opko Health's Interest Expenses stood at $11.4 million, which was down 3457.0% from $70.3 million recorded in Q2 2025.
  • Opko Health's 5-year Interest Expenses high stood at $70.3 million for Q2 2025, and its period low was $2.7 million during Q1 2022.
  • Its 5-year average for Interest Expenses is $10.0 million, with a median of $4.3 million in 2021.
  • Per our database at Business Quant, Opko Health's Interest Expenses crashed by 5065.8% in 2022 and then soared by 75974.33% in 2025.
  • Quarter analysis of 5 years shows Opko Health's Interest Expenses stood at $4.3 million in 2021, then decreased by 23.35% to $3.3 million in 2022, then grew by 4.57% to $3.5 million in 2023, then soared by 312.4% to $14.2 million in 2024, then fell by 20.24% to $11.4 million in 2025.
  • Its last three reported values are $11.4 million in Q3 2025, $70.3 million for Q2 2025, and $15.5 million during Q1 2025.